Eastman Chemical (NYSE: EMN) reported Q4 EPS of $1.69, $0.19 better than the analyst estimate of $1.50. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.16 billion.

2021 Outlook
Commenting on the outlook for full-year 2021, Costa said: “We enter 2021 having delivered record fourth-quarter 2020 adjusted earnings per share (EPS) and strong free cash flow, as the global economy continues to recover. However, we still face uncertainty due to COVID-19 as we move forward into 2021. In this uncertainty, I am incredibly proud of how our team is focused on what we can control, starting with growing new business revenue by leveraging our innovation-driven growth model, which is enabling us to perform better than our recovering end markets, particularly for many of our specialty products. We also continue to aggressively manage costs and remain focused on disciplined capital allocation. Building on our strong recovery in the fourth quarter, we expect 2021 adjusted EPS to be 20 to 30% higher than 2020 adjusted EPS.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.